Recursion Pharmaceuticals, Inc. (BMV:RXRX)
105.75
+6.75 (6.82%)
At close: Aug 14, 2025
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of 46.89 billion as of August 15, 2025. Its market cap has increased by 14.55% in one year.
Market Cap
46.89B
Enterprise Value
38.72B
Revenue
1.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
105.75
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from 101.17B to 46.89B, a decrease of -53.65%. That is a compound annual growth rate of -16.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 46.89B | -15.60% |
Dec 31, 2024 | 55.56B | 53.86% |
Dec 29, 2023 | 36.11B | 26.67% |
Dec 30, 2022 | 28.51B | -51.96% |
Dec 31, 2021 | 59.35B | -41.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Wal-Mart de México | 980.35B |
Grupo Financiero Banorte | 465.57B |
Arca Continental | 336.74B |
Industrias Peñoles | 207.74B |
GMéxico Transportes | 140.71B |
FIBRA Prologis | 113.79B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 99.44B |
Fibra UNO | 98.60B |